Peter Thornton's most recent trade in Avadel Pharmaceuticals plc - ADR was a trade of 11,000 Ordinary Shares done . Disclosure was reported to the exchange on July 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avadel Pharma PLC (ADR) | Peter Thornton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2025 | 11,000 | 115,055 (0%) | 0% | 0 | Ordinary Shares | |
| Avadel Pharma PLC (ADR) | Peter Thornton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2025 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Peter Thornton | Director | Purchase of securities on an exchange or from another person at price $ 8.04 per share. | 13 Jan 2025 | 10,000 | 104,055 (0%) | 0% | 8.0 | 80,450 | Ordinary Shares |
| Avadel Pharma PLC (ADR) | Peter Thornton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2024 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Peter Thornton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2024 | 11,000 | 94,055 (0%) | 0% | 0 | Ordinary Shares |